Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-07

FDA Approved: VILAZODONE HYDROCHLORIDE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for vilazodone hydrochloride from Accord Healthcare Inc., authorizing a generic version of the antidepressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vilazodone hydrochloride (vilazodone hydrochloride)

Snippet

SUPPL AP for VILAZODONE HYDROCHLORIDE (VILAZODONE HYDROCHLORIDE)